Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice
Se‐Hoon Lee(Samsung Medical Center), Sung‐Yup Cho(Seoul National University), Youngmin Yoon(Gwangju Institute of Science and Technology), Chang-Ho Park(Genome and Company (South Korea)), Jinyoung Sohn(Genome and Company (South Korea)), Jin-Ju Jeong(Genome and Company (South Korea)), Bu-Nam Jeon(Genome and Company (South Korea)), Mongjoo Jang(Genome and Company (South Korea)), Choa An(Genome and Company (South Korea)), Suro Lee(Samsung Medical Center), Yun Yeon Kim(Gwangju Institute of Science and Technology), Gihyeon Kim(Gwangju Institute of Science and Technology), Sujeong Kim(Hoseo University), Yun-Jae Kim(Gwangju Institute of Science and Technology), Gwang Bin Lee(Yonsei University), Eun Ju Lee(Genome and Company (South Korea)), Sang Gyun Kim(Hoseo University), Hong Sook Kim(Samsung Medical Center), Yeongmin Kim(Gwangju Institute of Science and Technology), Hyun Kim(Samsung Medical Center), Hyun Suk Yang(Hoseo University), Sarang Kim(Hoseo University), Seonggon Kim(Hoseo University), Hayung Chung(Korea Basic Science Institute), Myeong Hee Moon(Yonsei University), Myung Hee Nam(Korea Basic Science Institute), Jee Young Kwon(Jackson Laboratory), Sungho Won(Seoul National University), Joon-Suk Park(Daegu-Gyeongbuk Medical Innovation Foundation), George M. Weinstock(Jackson Laboratory), Charles Lee(Ewha Womans University), Kyoung Wan Yoon(Hoseo University), Hansoo Park(Gwangju Institute of Science and Technology)
Cited by 312
Abstract
Related Papers
No related papers found
Powered by citation graph analysis